These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 15111862

  • 1. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J, Xue L, Husak VA, Ellinger J, Singh G, Zamora PO, Greisler HP.
    J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
    [Abstract] [Full Text] [Related]

  • 2. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J, Xue L, Husak VA, Ellinger J, Greisler HP.
    Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
    Lin PH, Bush RL, Yao Q, Lumsden AB, Chen C.
    J Surg Res; 2004 May 01; 118(1):45-52. PubMed ID: 15093716
    [Abstract] [Full Text] [Related]

  • 4. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model.
    Freeman J, Chen A, Weinberg RJ, Okada T, Chen C, Lin PH.
    Ann Vasc Surg; 2018 May 01; 49():295-303. PubMed ID: 29197605
    [Abstract] [Full Text] [Related]

  • 5. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
    Cagiannos C, Abul-Khoudoud OR, DeRijk W, Shell DH, Jennings LK, Tolley EA, Handorf CR, Fabian TC.
    J Vasc Surg; 2005 Nov 01; 42(5):980-8. PubMed ID: 16275457
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization.
    Begovac PC, Thomson RC, Fisher JL, Hughson A, Gällhagen A.
    Eur J Vasc Endovasc Surg; 2003 May 01; 25(5):432-7. PubMed ID: 12713782
    [Abstract] [Full Text] [Related]

  • 13. The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study.
    Akers DL, Du YH, Kempczinski RF.
    J Vasc Surg; 1993 Jul 01; 18(1):10-5. PubMed ID: 8326650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
    Shemesh D, Goldin I, Hijazi J, Zaghal I, Berelowitz D, Verstandig A, Olsha O.
    J Vasc Surg; 2015 Jul 01; 62(1):115-22. PubMed ID: 25770987
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transgraft infusion of heparin to prevent early thrombosis of expanded PTFE grafts in canine femoral veins.
    Chen C, Hughes JD, Mattar SG, Hanson SR, Lumsden AB.
    Ann Vasc Surg; 1996 Mar 01; 10(2):147-55. PubMed ID: 8733867
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.